reported that an NSCLC patient (Case 18 in Table 1) had the same BRAF mutation on exon 11 (p. G469A) before and after transformation from LUAD into LSCC after immunotherapy resistance (17), indicating the possibility of a common cell or origin. Here, BRAF is linked to non-small cell lung carcinoma.